spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

ACG promotes Susheel Pillai as the new CEO for Inspection Business

ACG World


ACG, a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry, today announced the promotion of Susheel Pillai as the new CEO of ACG Inspection.

Pillai has been associated with ACG for the last 16 years and has been part of the group's different business units in various capacities. He was previously the Head of India operations as well as Global Sales Head. In his new role, in addition to growing the business of Inspection and Track & Trace Systems, he will also be responsible for introducing new technology, onboarding key talent, and extending ACG Inspection's footprint across the globe. He will be based out of Mumbai.

With close to 30 years of a proven track record of managing international business, he has been closely involved in designing and implementing transformational initiatives of the group, executing core business development strategies, building sales organisations across the globe as well as developing emerging leaders. He takes over from Ettore Cucchetti, who has decided to move back to his home country following five successful years at ACG.

Commenting on the appointment, Karan Singh, MD, ACG, said: "Susheel has played an instrumental role in developing and expanding the ACG Inspections portfolio. He is the perfect fit for the exciting and challenging role, as the focus begins to shift towards Industry 4.0."
phone +91 022 7186 2362 / +91 022 7186 2363
web https://www.acg-world.com/
email D Bhabrekar Nagar Road Mumbai, Maharashtra 400067, IN
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Northway Biotechpharma enters into Development and Manufacturing Agreement with Synklino

Vilnius, Lithuania, and Copenhagen, Denmark – December 18th 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Synklino, a company active in developing a therapeutic protein based therapy as treatment for cytomegalovirus (CMV) infection, announced today that they entered into a Development and Manufacturing Agreement for the recombinant fusion protein SYNx, which Synklino aims to bring into clinical trials.
More info >>


White Papers

Clinical Trial Disclosure Management: Build vs. Buy

TrialScope

Because software development is our core competency, TrialScope continues to make a significant investment in our technology. We employ agile methodologies to ensure that we can maintain a continuing level of responsiveness as disclosure requirements evolve across registries and regions.
More info >>

Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement